Therefore, it can alter the MEK1/2 as well as Akt/PKB transducers in androgen-dependent prostate carcinoma cells (LNCaP) along with the downregulation of cyclins D1/D3 and cyclin-dependent kinase (CDK) 4/6. Here, AKT1 is linked to prostate carcinoma.